1,777
Views
0
CrossRef citations to date
0
Altmetric
Research Articles

Testosterone, sex hormone-binding globulin and dehydroepiandrosterone levels and cervical length of Egyptian women with a history of recurrent miscarriages, polycystic ovary syndrome and without the conditions at three stages of pregnancy

, , &
Article: 2163625 | Received 30 Apr 2022, Accepted 17 Dec 2022, Published online: 23 Jan 2023

References

  • Ashaq, L., Al Mazer, Y. and Al Qahtani, N., 2017. Recurrent pregnancy loss in patients with polycystic ovary syndrome: a case control study. Open Journal of Obstetrics and Gynecology, 07 (11), 1073–1085. http://www.scirp.org/journal/ojog
  • Ashraf, S., et al., 2019. Hyperandrogenism in polycystic ovarian syndrome and role of CYP gene variants: a review. Egyptian Journal of Medical Human Genetics, 20 (1), 25.
  • ASRM – The American Society for Reproductive Medicine. 2020. Definitions of infertility and recurrent pregnancy loss: a committee opinion practice committee of the American Society for reproductive medicine. Fertility and Sterility, 113 (3), 533–534.
  • Benjamin, J. J., et al., 2021. DHEA and polycystic ovarian syndrome: meta-analysis of case-control studies. PLoS One, 16 (12), e0261552.
  • Berghella, V., et al., 1997. Cervical ultrasonography compared with manual examination as a predictor of 7; preterm delivery. American Journal of Obstetrics and Gynecology, 177 (4), 723–730.
  • Bortoletto, T.G., et al., 2021. Cervical length varies considering different populations and gestational outcomes: results from a systematic review and meta-analysis. PLoS One, 16 (2), e0245746.
  • Chakraborty, P., et al., 2013. Recurrent pregnancy loss in polycystic ovary syndrome: role of hyperhomocysteinemia and insulin resistance. PLoS One, 8 (5), e64446.
  • Chen, M.J., et al., 2006. Low sex hormone-binding globulin is associated with low high-density lipoprotein cholesterol and metabolic syndrome in women with PCOS. Human Reproduction, 21 (9), 2266–2271.
  • Cocksedge, K.A., et al., 2009. How common is polycystic ovary syndrome in recurrent miscarriage. Reproductive Biomedicine Online, 19 (4), 572–576.
  • Cocksedge, K.A., et al., 2008. Does free androgen index predict subsequent pregnancy outcome in women with recurrent miscarriage? Human Reproduction, 23 (4), 797–802.
  • Dendana, M., et al., 2018. Common genetic variants in the sex hormone-binding globulin (SHBG) gene in idiopathic recurrent pregnancy loss: a case-control study. Translational Medicine Communications, 3 (1), 5.
  • Deswal, R., Yadav, A. and Dang, A.S., 2018. Sex hormone binding globulin – an important biomarker for predicting PCOS risk: a systematic review and meta-analysis. Systems Biology in Reproductive Medicine, 64 (1), 12–24.
  • Di Prima, F.A.F., et al., 2011. Antiphospholipid Syndrome during pregnancy: the state of the art. Journal of Prenatal Medicine, 5 (2), 41–53.
  • Diejomaoh, M.F.E., 2015. Recurrent spontaneous miscarriage, is still a challenging diagnostic and therapeutic quagmire. Medical Principles and Practice, 24 (suppl 1), 38–55.
  • Dunn, J.F., Nisula, B.C. and Rodbard, D., 1981. Transport of steroid hormones: binding of 21 endogenous steroids to both testosterone-binding globulin and corticosteroid-binding globulin in human plasma. The Journal of Clinical Endocrinology and Metabolism, 53 (1), 58–68.
  • Eapen, A., et al., 2021. Mean differences in maternal body mass index and recurrent pregnancy loss: a systematic review and meta-analysis of observational studies. Fertility and Sterility, 116 (5), 1341–1348.
  • El Hachem, H., et al., 2017. Recurrent pregnancy loss: current perspectives. International Journal of Women’s Health, 9, 331–345.
  • ESHRE – The European Society of Human Reproduction and Embryology. 2017. Early Pregnancy Guideline Development Group. Recurrent Pregnancy Loss, version 2.
  • Gabbai, D., et al., 2018. Pregnancy outcomes among patients with recurrent pregnancy loss and uterine anatomic abnormalities. Journal of Perinatal Medicine, 46 (7), 728–734.
  • Gleicher, N. and Barad, D.H., 2011. Dehydroepiandrosterone (DHEA) supplementation in diminished ovarian reserve (DOR). Reproductive Biology and Endocrinology, 9, 67.
  • Goodarzi, M.O., Carmina, E. and Azziz, R., 2015. DHEA, DHEAS and PCOS. The Journal of Steroid Biochemistry and Molecular Biology, 145, 213–225.
  • Hennessy, M., et al., 2021. Clinical practice guidelines for recurrent miscarriage in high-income countries: a systematic review. Reproductive Biomedicine Online, 42 (6), 1146–1171.
  • Hernandez-Andrade, E., et al., 2012. Ransabdominal evaluation of uterine cervical length during pregnancy fails to identify a substantial number of women with a short cervix. The Journal of Maternal-Fetal & Neonatal Medicine, 25 (9), 1682–1689.
  • Hogeveen, K.N., et al., 2002. Human sex hormone-binding globulin variants associated with hyperandrogenism and ovarian dysfunction. The Journal of Clinical Investigation, 109 (7), 973–981.
  • HSE – Health Service Executive, Ireland. 2016. National standards for bereavement care following pregnancy loss and perinatal death. Version 1.15
  • Huang, M., et al., 2018. Relationship between dietary carbohydrates intake and circulating sex hormone-binding globulin levels in postmenopausal women. Journal of Diabetes, 10 (6), 467–477.
  • Huchon, C., et al., 2016. Pregnancy loss: French clinical practice guidelines. European Journal of Obstetrics, Gynecology, and Reproductive Biology, 201, 18–26.
  • Kakoly, N.S., et al., 2017. Group-based developmental BMI trajectories, polycystic ovary syndrome, and gestational diabetes: a community-based longitudinal study. BMC Medicine, 15 (1), 195.
  • Kaur, R. and Gupta, K., 2016. Endocrine dysfunction and recurrent spontaneous abortion: an overview. International Journal of Applied & Basic Medical Research, 6 (2), 79–83.
  • Li, D., et al., 2021. The role of immune cells in recurrent spontaneous abortion. Reproductive Sciences, 28 (12), 3303–3315.
  • Lin, X.F., et al., 2015. Exploring the significance of sex hormone-binding globulin examination in the treatment of women with polycystic ovarian syndrome (PCOS). Clinical and Experimental Obstetrics & Gynecology, 42 (3), 315–320.
  • Liu, X., et al., 2021. Women with PCOS with a history of early pregnancy loss show a higher risk of gestational diabetes mellitus. International Journal of General Medicine, 14, 6409–6416.
  • Lovvik, T.S., et al., 2015. Pregnancy and perinatal outcomes in women with polycystic ovary syndrome and twin births: a population-based cohort study. An International Journal of Obstetrics and Gynaecology, 122 (10), 1295–1302.
  • Magnus, M.C., et al., 2019. Role of maternal age and pregnancy history in risk of miscarriage: prospective register-based study. BMJ, 364, l869.
  • Maryam, K., et al., 2012. The comparison of insulin resistance frequency in patients with recurrent early pregnancy loss to normal individuals. BMC Research Notes, 5, 133.
  • Mayrhofer, D., et al., 2020. The prevalence and impact of polycystic ovary syndrome in recurrent miscarriage: a retrospective cohort study and meta-analysis. Journal of Clinical Medicine, 9 (9), 2700.
  • Moran, C., et al., 2015. Adrenal androgen excess and body mass index in polycystic ovary syndrome. The Journal of Clinical Endocrinology and Metabolism, 100 (3), 942–950.
  • Moran, L.J., et al., 2016. Long-term effects of a randomised controlled trial comparing high protein or high carbohydrate weight loss diets on testosterone, shbg, erectile and urinary function in overweight and obese men. PLoS One, 11 (9), e0161297.
  • Nassour-Mokhtari, I., et al., 2020. Inherited thrombophilia and recurrent pregnancy loss: a single-center case-control study in North-Western Algeria. Egyptian Journal of Medical Human Genetics, 21 (1), 33.
  • Naver, K.V., et al., 2014. Increased risk of preterm delivery and pre-eclampsia in women with polycystic ovary syndrome and hyperandrogenaemia. An International Journal of Obstetrics and Gynaecology, 121 (5), 575–581.
  • Ng, K.Y.B., et al., 2021. Systematic review and meta‑analysis of female lifestyle factors and risk of recurrent pregnancy loss. Scientific Reports, 11 (1), 7081.
  • Nigro, G., et al., 2011. Role of the infections in recurrent spontaneous abortion. The Journal of Maternal-Fetal & Neonatal Medicine, 24 (8), 983–989.
  • O’Hara, S., et al., 2015. The maternal cervix: Why, when and how? Sonography, 2 (4), 74–83.
  • Papastefanou, I., et al., 2016. First trimester cervical length is associated with mid-trimester loss. The Journal of Maternal-Fetal & Neonatal Medicine, 29 (1), 51–54.
  • Patki, A. and Chauhan, N., 2016. An epidemiology study to determine the prevalence and risk factors associated with recurrent spontaneous miscarriage in India. Journal of Obstetrics and Gynaecology of India, 66 (5), 310–315.
  • Qu, X. and Donnelly, R., 2020. Sex hormone-binding globulin (SHBG) as an early biomarker and therapeutic target in polycystic ovary syndrome. International Journal of Molecular Sciences, 21 (21), 8191.
  • RCOG – The Royal College of Obstetricians and Gynaecologists., 2011. The Investigation and Treatment of Couples with Recurrent First-trimester and Second-trimester Miscarriage. Guideline No. 17.
  • Rossen, L.M., Ahrens, K.A. and Branum, A.M., 2018. Trends in risk of pregnancy loss among us women, 1990–2011. Paediatric and Perinatal Epidemiology, 32 (1), 19–29.
  • Rotterdam Criteria – The Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group), 2004. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertility and Sterility, m81 (1), 19–25.
  • Seow, M., et al., 2018. The use of dehydroepiandrosterone-treated rats is not a good animal model for the study of metabolic abnormalities in polycystic ovary syndrome. Taiwanese Journal of Obstetrics & Gynecology, 57 (5), 696–704.
  • Sharma, R., et al., 2013. Lifestyle factors and reproductive health: taking control of your fertility. Reproductive Biology and Endocrinology, 11, 66. http://www.rbej.com/content/11/1/66.
  • Souka, A.P., et al., 2011. Cervical length changes from the first to second trimester of pregnancy, and prediction of preterm birth by first-trimester sonographic cervical measurement. Journal of Ultrasound in Medicine, 30 (7), 997–1002.
  • Spencer, K., et al., 2005. First trimester sex hormone-binding globulin and subsequent development of preeclampsia or other adverse pregnancy outcomes. Hypertension in Pregnancy, 24 (3), 303–311.
  • Stephenson, M. and Kutteh, W., 2007. Evaluation and management of recurrent early pregnancy loss. Clinical Obstetrics and Gynecology, 50 (1), 132–145.
  • Tawfeek, M.A., et al., 2017. Sex hormone binding globulin as a valuable biochemical marker in predicting gestational diabetes mellitus. BMC Women’s Health, 17 (1), 18.
  • Tian, L., et al., 2007. Insulin resistance increases the risk of spontaneous abortion after assisted reproduction technology treatment. The Journal of Clinical Endocrinology and Metabolism, 92 (4), 1430–1433.
  • Turki, R.F., et al., 2016. Associations of recurrent miscarriages with chromosomal abnormalities, thrombophilia allelic polymorphisms and/or consanguinity in Saudi Arabia. BMC Medical Genetics, 17 (S1), 69.
  • Valdimarsdottir, R., et al., 2021. Pregnancy outcome in women with polycystic ovary syndrome in relation to second-trimester testosterone levels. Reproductive Biomedicine Online, 42 (1), 217–225.
  • Van Dijk, M.M., et al., 2020. Recurrent pregnancy loss: diagnostic workup after two or three pregnancy losses? A systematic review of the literature and meta-analysis. Human Reproduction Update, 26 (3), 356–367.
  • Vanky, T.S. and Lovvik, T.S., 2020. Polycystic ovary syndrome and pregnancy – from a clinical perspective. Current Opinion in Endocrine and Metabolic Research, 12, 8–13.
  • Venetis, C.A., et al., 2014. Clinical implications of congenital uterine anomalies: a meta-analysis of comparative studies. Reproductive Biomedicine Online, 29 (6), 665–683.
  • Vomstein, K., et al., 2021. Immunological risk factors in recurrent pregnancy loss: guidelines versus current state of the art. Journal of Clinical Medicine, 10 (4), 869.
  • Wulff, C.B., et al., 2018. Transvaginal sonographic cervical length in first and second trimesters in a low-risk population: a prospective study. Ultrasound in Obstetrics & Gynecology, 51 (5), 604–613.
  • Zain, M.M. and Norman, R.J., 2008. Impact of obesity on female fertility and fertility treatment. Women’s Health, 4 (2), 183–194.